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Abstract Crosslinking of the WEHI 231 lymphoma B cell
receptor (BCR) leads to growth arrest followed by apoptosis.
In a study of the role of lysosomal cysteine proteinases in BCR-
mediated apoptosis we provide evidence that commitment to
apoptosis correlates with a time-dependent increase in caspase
and cathepsin activities. We also show that activation of cathep-
sins is a caspase-independent process, and caspase cascade acti-
vation is independent of lysosomal endopeptidases. BCR-induced
nuclear fragmentation was not prevented, but rather delayed in
the absence of detectable caspase and cathepsin activities, sug-
gesting that BCR-driven apoptosis of these cells may use an
alternative proteolytic mechanism independent of caspases and
cathepsins.
' 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The B cell lymphoma WEHI 231 cell line has been used as a
model to study immature B cell tolerance, based on its ca-
pacity to undergo growth arrest and programmed cell death
on B cell receptor (BCR) crosslinking by anti-IgM antibodies
[1,2]. Because of its very long time course, the mechanism of
cell death induced by signal transduction from the BCR may
be di¡erent from other mechanisms of apoptosis such as the
Fas-mediated or anti-tumor drug-induced cell death [3]. Mo-
lecular mechanisms operating in BCR-mediated apoptosis are
characterized by activation and processing of procaspase-7 [4].
The pathways leading to activation of the e¡ector caspase
cascade in BCR-mediated apoptosis are unclear and the rele-
vance of the low levels of BCR-mediated caspase 9 on pro-
cessing of procaspase 7 is under debate [4^6]. BCR crosslink-
ing also induces calpain, a calcium-dependent protease, imply-
ing that calpain processes procaspase 7 [7,8]. Despite the char-
acteristic time-dependent increases in caspase/DEVDase
activity in anti-IgM-induced apoptosis in WEHI 231, it ap-
pears that such signalling can lead to the execution of cells
independently of caspase activation, assigning an execution
role to the lysosomal endopeptidase, cathepsin B [5]. Cathep-
sins, papain-like lysosomal proteinases, are also implicated in
several other apoptotic pathways [9]. For instance, disruption
of the lysosomal membrane with lysosome-directed oxidative
stress or lysosomotropic detergents causes a release of lyso-
somal content into the cytoplasm and apoptotic dismiss of
cells [10,11]. In tumor necrosis factor (TNF)-induced apopto-
sis of tumor ¢brosarcoma cell WEHI-S and cervix carcinoma
ME-180as cells, cathepsin B was assigned a dominant execu-
tion role; however, it appears to play a minor role in TNF-
induced apoptosis in primary cells [12]. Furthermore, deletion
of the cathepsin B gene in mice reduced TNF-K-associated
hepatocyte apoptosis by inhibiting mitochondrial release of
cytochrome c and the activation of caspases 9 and 3 [13]. A
molecular mechanism of the involvement of cathepsin B in
mitochondrial release of cytochrome c appears to be via cleav-
age of the Bcl-2 family member Bid, where truncated Bid
triggers the intrinsic apoptosis pathway, by causing release
of cytochrome c from mitochondria and subsequent caspase
activation [14].
The aim of this study was to further elucidate the proteo-
lytic events in BCR-mediated apoptosis of WEHI 231 cells.
We investigated the relation of cell death progression to acti-
vation of cathepsins and caspases in order to identify any
connection between the two processes. The present work re-
veals a concomitant but independent increase in caspase and
cathepsin activities on surface IgM crosslinking. Inhibition of
FRase as well as DEVDase activity failed to inhibit BCR-
triggered cell death, implying this to be an execution process
independent of cathepsins and caspases.
2. Materials and methods
2.1. Cell culture
The WEHI 231 cell line was cultured in RPMI1640 (Sigma, Chem-
ical Co., St. Louis, MO, USA) with 10% fetal calf serum (Gibco),
2 mM L-glutamine, 100 U/ml penicillin, 100 Wg/ml streptomycin,
10 mM HEPES and 50 WM 2-mercaptoethanol (Sigma), at 37‡C, in
humidi¢ed air with 5% CO2. The surface IgM of WEHI 231 cells was
crosslinked with 10 Wg/ml of goat anti-IgM (Sigma). For inhibition
studies cells were seeded in 6- or 24-well plates at 0.25U106 cells/ml in
complete medium and (2S,3S)-trans-epoxysuccinyl-leucylamido-3-
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methyl-butane ethyl ester (E-64d; Peptide Institute, Osaka, Japan), or
benzyloxycarbonyl-Val-Ala-Asp.£uoromethyl ketone (z-VAD.fmk;
Bachem AG, Bubbendorf, Switzerland) added in adequate concentra-
tions and 6 0.5% (v/v) dimethylsulfoxide (DMSO). The correspond-
ing volume of solvent was added to the control cultures. Cells were
incubated for up to 66 h.
2.2. Proliferation assay
Cells (1U104/well/100 Wl) were plated in 96-well £at-bottom micro-
titer plates and cultured in the absence or presence of di¡erent con-
centrations of E-64d (Peptide Institute) for 23 h at 37‡C, 5% CO2. To
determine the proliferative capacity, cells were exposed to MTS assay
(CellTiter 960 AQueous one solution cell proliferation assay; Promega,
Madison, WI, USA). In brief, MTS reagent (10 Wl/well) was added
and the cells were incubated at 37‡C for 1 h. The absorbance at
490 nm was measured with microplate reader (Bio-Rad, Laboratories
Inc., Sunnyvale, CA, USA). Each experiment was performed in qua-
druplicate and repeated at least three times.
2.3. Flow cytometry analysis of the DNA content and cell cycle analysis
Apoptosis was evaluated by staining cellular DNA with propidium
iodide (PI). Cells (105-106) were washed in phosphate-bu¡ered saline
and permeabilized with ice-cold methanol. They were then washed
and treated with RNAse (20 Wg/ml) for 30 min at 37‡C. Cells were
stained with PI solution and analyzed by £uorescence-activated cell
sorting (FACS Calibur; Becton-Dickinson, San Jose, CA, USA).
Data were evaluated using the CellQuest software. Apoptosis was
determined as the percentage of cells located in the hypoploid sub-
G0/G1 peak of the cell cycle.
2.4. Analysis of internucleosomal DNA fragmentation
The cleavage of DNA into nucleosomal fragments was analyzed by
fractionation on agarose gel. Cells were lysed in 100 mM Tris^HCl
bu¡er (pH 8.5) containing 5 mM EDTA, 0.2% sodium dodecyl sul-
fate, 200 mM NaCl, and 200 Wg/ml proteinase K, and incubated over-
night at 37‡C. Nucleic acids were recovered with one volume of iso-
propanol, treated with RNaseA (50 Wg/ml), and the solution
equivalent to 1U105 cells was fractionated by electrophoresis on
1.8% agarose gel. The DNA bands were visualized by ethidium bro-
mide staining and evaluated by comparison with a 100-bp DNA lad-
der standard.
2.5. Measurement of DEVDase activity
The activation of caspase zymogen in cell extracts was followed
£uorometrically by monitoring 7-amino-4-tri£uoromethyl coumarin
(AFC) release from the Ac-DEVD.AFC substrate. Cell extracts
were prepared by pelleting, lysing and sonicating cells in 0.1 M phos-
phate bu¡er pH 6.0 containing 0.1% Triton X-100. Cleared cell ex-
tracts (20 Wg cellular proteins) were incubated in assay bu¡er (20 mM
Pipes, 100 mM NaCl, 0.1% (w/v) CHAPS, 10% (w/v) sucrose, and
10 mM dithiothreitol (DTT), pH 7.2), and incubated at 37‡C for
30 min. Activation was analyzed by adding the substrate Ac-DEV-
D.AFC (100 WM) in 96-well microplate format to a 37‡C thermojack-
eted £uorescence microplate reader (LS-50 B, Luminescence Spec-
trometer, Perkin Elmer Inc., Wellesley, MA, USA). Free AFC was
monitored at an excitation wavelength of 405 nm and an emission
wavelength of 510 nm. The reaction was followed continuously for
60 min. Assays performed without cell lysate were used as background
controls. DMSO, which was used as a solvent for the inhibitors,
served as a negative control. Steady-state hydrolysis rates were ob-
tained from the linear part of the curves. Data were expressed as
increase in £uorescence as a function of time (vF/vt).
2.6. Measurement of FRase and RRase activity
Cysteine-endopeptidases activities in cell extracts were tested
against z-Arg-Arg.AMC (AMC, 7-amino-4-methyl coumarin), a sub-
strate for cathepsin B, and z-Phe-Arg.AMC, which is hydrolyzed by a
number of cathepsins such as L, B and S. Cell extracts were prepared
as described above, and enzymatic activities were measured in 40 Wg
of whole cell extracts by adding a reaction bu¡er (100 mM phosphate
bu¡er, pH 6.0, containing 250 mM sucrose, 1 mM EDTA and 5 mM
DTT) and 100 WM z-Arg-Arg.AMC or 100 WM z-Phe-Arg.AMC as
substrates. The intensity of £uorescence of the liberated AMC was
then measured (Vex = 355 nm, Vem = 460 nm). Release of the product
was measured continuously for 60 min at 37‡C and data evaluated as
described above.
3. Results
3.1. Activation of cathepsins is characteristic of apoptosis
induced by surface IgM crosslinking on WEHI 231
Cathepsins are activated following BCR-mediated apopto-
sis, suggesting their involvement in the proteolytic machinery
of programmed cell death. The kinetics of caspase and cathep-
sin activation were determined by incubating cells with anti-
IgM antibodies for up to 66 h. Cells were harvested at di¡er-
ent time points and the cell extracts examined for the ability
to cleave speci¢c substrates. Ac-DEVD.AFC was used as a
speci¢c substrate of caspase-3-like enzymes [15]. DEVDase
activity started to be observed at 18 h and reached maximum
levels at 38 h (Fig. 1). Similarly, the activity of cathepsins was
evaluated in cell extracts against z-FR.AMC and z-RR.AMC
substrates. Increases in the basic levels of FR-, and RR-like
activity were detected 8 h after anti-IgM incubation, with
maximum levels at 38 h, and a decline thereafter (Fig. 1).
z-FR.AMC hydrolyzed three-fold faster than z-RR.AMC
which is hydrolyzed by cathepsin B only (data not shown).
Fig. 1. Time-dependent activation of caspases and cathepsins in
BCR-induced apoptosis. Cells (0.25U106 cells/ml) were cultured in
the presence of 10 Wg/ml of anti-IgM antibody for the times indi-
cated. Cell extracts were analyzed for their proteolytic activity
towards Ac-DEVD.AFC (DEVDase activity, solid line) and
z-FR.AMC (FRase activity, dotted line). The increase in £uores-
cence as a function of time (vF/vt) denoted the amount of released
AMC or AFC. Results are representative of multiple experiments.
Fig. 2. Concentration-dependent inhibition of endogenous cathepsin
activity. Cells (0.25U106 cells/ml) were incubated with various con-
centrations of E-64d for 30 min. Cell extracts were analyzed for en-
zymatic activity against z-FR.AMC synthetic substrate. The inhibi-
tory potential of E-64d is expressed as the percentage of maximal
FRase activity. All values represent means of triplicate determina-
tionsS S.D. * denotes undetectable levels.
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3.2. Inhibition of cathepsins does not relieve antigen
receptor-mediated growth arrest or apoptosis in WEHI 231
The cell-permeable E-64d, which selectively inhibits cysteine
endopeptidases (including cathepsins B and L, and calpains),
was used to determine the concentration and time dependence
of in vivo inhibition of cathepsin activity. However, incuba-
tion of cells for 30 min with E-64d at concentrations higher
than 10 WM inhibited the total cellular FR- and RR-like ac-
tivity (Fig. 2). E-64d was shown not to be cytotoxic or to have
any e¡ect on cell proliferation by MTT assays, at concentra-
tions up to 150 WM (data not shown).
Our results indicate the involvement of cathepsins in anti-
IgM-induced cell death as suggested by their activation ki-
netics which, similar to those of the caspases, accompany ap-
optosis. This prompted us to examine whether inhibition of
endogenous cathepsin activity could modulate this process.
Here we present evidence that inhibition of cathepsin activity
did not protect cells from anti-IgM-induced apoptosis. Pre-
treatment of WEHI 231 cells with up to 150 WM of E-64d
for 1 h prior to and following anti-IgM treatment, had no
e¡ect on the cell cycle pro¢le (see below, Fig. 5A, E-64d
row). Growth arrest was observed by accumulation of cells
in G0/G1 phase and a decrease in the S phase of the cell cycle
at 24 h posttreatment, and apoptosis was determined as the
fraction of cells in the subG0 peak observed at 48 h. The e¡ect
of E-64d on the anti-IgM-induced apoptotic process was also
examined by looking for internucleosomal DNA fragmenta-
tion. Substantial DNA laddering was clearly detectable fol-
lowing 48 h of anti-IgM treatment and was not protected
by preincubating the cells with 100 WM E64d (Fig. 3A).
Further evidence that the apoptotic process progresses in
the absence of detectable levels of cathepsin activity comes
from the kinetic studies of DEVDase activation during the
course of apoptotic induction. Incubation of WEHI 231 cells
with 25 WM E-64d for 1 h prior to and following IgM cross-
linking completely inhibited endogenous FRase activity
throughout a 66-h experiment, but did not a¡ect the time
course and level of DEVDase activation (Fig. 3B).
3.3. BCR-mediated increase in cathepsin activity is caspase
independent
Concentration-dependent inhibition of cathepsin/FRase ac-
tivity by z-VAD.fmk has been determined in resting, but not
in apoptotic cells. WEHI 231 cells were incubated with 25 or
150 WM of z-VAD.fmk for 1 h and their extracts examined for
FRase activity. Basic levels of cathepsin activity were only
moderately a¡ected by low concentrations (25 WM) but almost
completely inhibited by 150 WM z-VAD.fmk. To examine theFig. 3. Cysteine proteinase inhibitor E-64d does not a¡ect BCR-in-
duced cell death. Cells (5U105 cells/ml) were incubated alone or
with E-64d (100 WM) for 1 h before addition of anti-IgM antibody
(10 Wg/ml), and harvested at the times indicated. A: DNA fragmen-
tation assays. Cells were harvested for isolation of total DNA after
48 h of incubation. Electrophoresis was on 1.8% agarose gels.
B: Enzyme activity assays. Cells were pretreated with (black bars)
or without (open bars) 25 WM E-64d prior to anti-IgM incubation.
Cells were harvested at indicated times and 40 Wg of total cell pro-
teins was analyzed for FRase activity. All values represent means of
triplicate determinationsS S.D. C: Similarly, cells were treated with
50 WM E-64d (thick line bars), with 10 Wg/ml anti-IgM (dotted line)
or a combination of both (thin line). Twenty Wg of total cell pro-
teins was analyzed for DEVD-like activity. All values are means of
triplicate determinations S S.D. These results are representative of
four independent experiments.
Fig. 4. E¡ects of fmk peptide inhibitors on the cathepsin activity in
resting and IgM-treated WEHI 231 cells. WEHI 231 cells (5U105
cells/ml) were treated with z-VAD.fmk for 1 h and harvested for ly-
sis or incubated with anti-IgM for 38 h and then lysed. Samples
were analyzed for FRase and DEVDase activity by incubating 40 or
20Wg of cell extracts with z-FR.AFC (benzyloxycarbonyl-Phe-Arg-
AFC), or Ac-DEVD.AMC (acetyl-Asp-Glu-Val-Asp-AMC), respec-
tively. Activity was measured with the £uorogenic substrates as de-
scribed. Data are expressed as increase in £uorescence as a function
of time (vF/vt).
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inhibiting e¡ects of z-VAD.fmk on BCR-mediated increases
in cathepsin activity, cells were preincubated with 25 or 150
WM z-VAD.fmk for 1 h prior to the addition of anti-IgM
antibodies, and harvested 38 h later. Substantial increases in
cathepsin B activity were detected in samples incubated even
in the presence of 150 WM z-VAD.fmk. DEVDase activity was
completely blocked throughout the time course of the experi-
ment. These results indicate that the BCR-mediated activation
of cathepsins is independent of the presence of active caspases
(Fig. 4).
3.4. BCR-mediated nuclear fragmentation proceeds in the
absence of RRase and DEVDase activity
Nuclear fragmentation and morphological changes were ob-
served to take place, even in the absence of detectable DEV-
Dase activity. Cells preincubated with z-VAD.fmk inhibitor
and treated with anti-IgM as above were harvested for
FACS analysis at di¡erent time intervals. High concentrations
(150 WM) of z-VAD.fmk led to a decrease in the fraction of
cells in the subG0 peak observed at 48 h after BCR ligation to
19%, compared to 41% in non-pretreated cells. Nevertheless,
at longer incubation periods, such as 60 h, a substantial pro-
portion (45%) of the cells was detected in the subG0 popula-
tion (Fig. 5A, z-VAD.fmk row). Thus, z-VAD.fmk did not
rescue cells from BCR-mediated nuclear fragmentation but
had rather delayed its onset.
A possible conclusion from the above experiments could be
that cathepsins act as an alternative execution pathway and
are perhaps responsible for the ¢nal caspase-independent ex-
ecution. To examine this possibility we inhibited both classes
Fig. 5. E¡ect of caspase and cathepsin inhibition on BCR-induced nuclear fragmentation. A: Cells (0.25U106 cells/ml) were incubated alone or
with z-VAD.fmk (100 WM), E-64d (100 WM), or a combination of both inhibitors for 1 h before addition of anti-IgM antibody (10 Wg/ml).
Cells were collected at the indicated times, pellets were permeabilized and stained with PI for cell cycle analysis. Apoptosis corresponds to the
amount of fragmented DNA in the hypoploid subG0/G1 peak of the cell cycle. Values are expressed in percentages. B: Cells (7U105 cells/ml)
were pretreated, with or without a combination of z-VAD.fmk and E-64d (100 WM, each), for 1 h and incubated with anti-IgM for 38 or 62 h
and then lysed. Samples were analyzed for DEVDase and FRase activity as described. Data are expressed as increase in £uorescence as a func-
tion of time (vF/vt). Results are representative of at least three independent experiments.
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of cysteine proteinases by incubating WEHI 231 with a com-
bination of 100 WM E-64d and 150 WM z-VAD.fmk. The
e¡ect of inhibition was observed by determining the percent-
age of cells in the subG0 fraction of the cell cycle. While this
fraction was decreased in cells incubated for 48 h and 60 h
with z-VAD.fmk, as compared to non-inhibited samples, no
additional e¡ect was observed in cells incubated with a com-
bination of the two inhibitors, z-VAD.fmk and E-64d (Fig.
5A, E-64D+z-VAD.fmk row). DEVDase and FRase activities
were suppressed throughout the time course of the experiment
(Fig. 5B). The failure of both caspase and cathepsin inhibitors
to rescue WEHI 231 from BCR-mediated apoptosis suggests
that the antigen receptor-driven apoptosis of these cells may
use an alternative mechanism independent of caspases and
cathepsins.
4. Discussion
Control of the apoptotic process plays a selective role in the
course of B cell maturation and is important for understand-
ing B cell function. Transmembrane signalling initiated by the
BCR is essential for various B cell activities including cell
activation, proliferation, anergy and deletion [16,17]. Our re-
sults have provided evidence that commitment of these cells to
antigen receptor-driven apoptosis correlates with time-depen-
dent increases in caspase and cathepsin activities. Such a cor-
relation does not, however, necessarily imply a direct causal
connection.
We further show that while the increases in anti-IgM-in-
duced cathepsin activity suggested their involvement in the
apoptotic process, inhibition of the papain-like lysosomal cys-
teine proteases (cathepsins) and calpains by E-64d was not
su⁄cient to alter the BCR-mediated apoptotic process or
the induced DEVDase activity and its time course. Time-de-
pendent increases in caspase activity are a hallmark of BCR-
mediated apoptosis and caspase-7 has been assigned a major
execution role in this process [3,4]. However, some other re-
ports indicate that BCR-mediated execution of WEHI 231
cells can also proceed in a caspase-independent manner [5].
Both apparently opposing statements are based on studies of
caspase function using the pan-caspase inhibitor z-VAD.fmk
at di¡erent concentrations. While the classical death receptor-
mediated apoptosis pathways are completely blocked by 1 WM
zVAD.fmk [18], several recent studies delineating the role of
caspases in apoptotic process have been conducted with con-
centrations of z-VAD.fmk up to 200 WM. Chloromethyl ke-
tone and fmk peptide inhibitors of caspases such as
z-VAD.fmk can also strongly inhibit cathepsins [18,19,20].
Such inhibition was observed at concentrations of z-VAD.fmk
higher than 10 WM [21], although it somewhat depends on the
cell type used [20]. It seems that the major reason for this
crossreactivity is the high reactivity of the halomethylketones
towards the active site Cys, since the secondary and tertiary
structures of caspases do not resemble those of cathepsins,
and the active site catalytic machinery is di¡erent [20]. Our
results support these data showing that halomethyl ketone
peptide inhibitors of caspases can at higher concentrations
inhibit the basic levels of cathepsin activity in resting cells.
We report herein that blocking DEVDase activity by pan-
caspase inhibitor z-VAD.fmk is not su⁄cient to rescue cells
from the BCR-mediated cell death but that it only delays its
onset. Furthermore, despite the non-speci¢c inhibition of
cathepsins by this inhibitor in resting cells, activity of cathep-
sins increased in cells undergoing apoptosis, implying a pos-
sible alternative proteolytic pathway. This possibility was,
however, neglected based on results showing that inhibiting
both classes of proteases by preincubating cells with a combi-
nation of z-VAD.fmk and E64d exhibited none of the addi-
tional protective e¡ects. BCR-mediated apoptosis progressed
in the absence of detectable DEVDase and FRase activities.
The failure of caspase and cathepsin inhibitors to rescue the
WEHI 231 immature B cells from antigen receptor-driven ap-
optosis suggests the involvement of yet another proteolytic
pathway.
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